Telemus Capital LLC continued to hold its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,980 shares of the medical instruments supplier’s stock at the end of the second quarter. Telemus Capital LLC’s holdings in DENTSPLY SIRONA were worth $517,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. First Manhattan Co. raised its stake in DENTSPLY SIRONA by 43.0% in the second quarter. First Manhattan Co. now owns 13,986 shares of the medical instruments supplier’s stock valued at $906,000 after buying an additional 4,208 shares in the last quarter. Emerald Advisers Inc. PA raised its stake in shares of DENTSPLY SIRONA by 16.9% in the second quarter. Emerald Advisers Inc. PA now owns 24,423 shares of the medical instruments supplier’s stock valued at $1,584,000 after buying an additional 3,524 shares during the period. S&CO Inc. raised its stake in shares of DENTSPLY SIRONA by 102.8% in the second quarter. S&CO Inc. now owns 15,564 shares of the medical instruments supplier’s stock valued at $1,009,000 after buying an additional 7,890 shares during the period. Grandfield & Dodd LLC raised its stake in shares of DENTSPLY SIRONA by 1.6% in the second quarter. Grandfield & Dodd LLC now owns 231,969 shares of the medical instruments supplier’s stock valued at $15,041,000 after buying an additional 3,573 shares during the period. Finally, Independent Franchise Partners LLP raised its stake in shares of DENTSPLY SIRONA by 3.3% in the second quarter. Independent Franchise Partners LLP now owns 1,543,414 shares of the medical instruments supplier’s stock valued at $100,074,000 after buying an additional 49,141 shares during the period. Institutional investors own 95.13% of the company’s stock.
Shares of DENTSPLY SIRONA Inc. (XRAY) traded down 0.52% on Wednesday, reaching $53.48. 2,168,342 shares of the company traded hands. The company’s market capitalization is $12.27 billion. DENTSPLY SIRONA Inc. has a one year low of $52.73 and a one year high of $65.68. The firm has a 50-day moving average price of $62.34 and a 200 day moving average price of $62.34.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, meeting the consensus estimate of $0.65. The company had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. DENTSPLY SIRONA’s revenue was down 2.9% compared to the same quarter last year. During the same period last year, the firm posted $0.76 earnings per share. Equities analysts forecast that DENTSPLY SIRONA Inc. will post $2.72 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be given a $0.0875 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 annualized dividend and a yield of 0.65%. DENTSPLY SIRONA’s payout ratio is -10.09%.
XRAY has been the topic of several recent research reports. UBS AG restated a “neutral” rating and issued a $59.00 price target (down from $62.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. BidaskClub downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $66.00 target price (down from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday. Finally, Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $66.25.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
